2mg Bortezomib Injection IP Product Specifications
Normal Smell
24-36 Months
Injection
(20C to 25C or 68F to 77F)
India
2mg Bortezomib Injection IP Trade Information
Cash in Advance (CID)
5000 Unit Per Month
7-10 Days
Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
All India
Product Description
2mg Bortezomib Injection IP is a high-quality medication used for the treatment of multiple myeloma and mantle cell lymphoma. The active ingredient in this injection, Bortezomib, works by blocking the action of certain proteins in cancer cells, thereby slowing down their growth and spread. This injection is manufactured, supplied, and distributed in India, ensuring that it meets all the necessary quality standards. It has a normal fermentation smell and can be stored at temperatures between 20C to 25C or 68F to 77F. The injection has a shelf life of 24-36 months, making it a reliable and efficient medication for cancer treatment.
FAQs of 2mg Bortezomib Injection IP:
Q: What is 2mg Bortezomib Injection IP used for?
A: This injection is used for the treatment of multiple myeloma and mantle cell lymphoma.
Q: How does 2mg Bortezomib Injection IP work?
A: Bortezomib, the active ingredient in this injection, blocks the action of certain proteins in cancer cells, thereby slowing down their growth and spread.
Q: What is the shelf life of 2mg Bortezomib Injection IP?
A: The injection has a shelf life of 24-36 months.
Q: What is the recommended storage temperature for 2mg Bortezomib Injection IP?
A: The injection can be stored at temperatures between 20C to 25C or 68F to 77F.
Q: Is 2mg Bortezomib Injection IP safe to use?
A: Yes, this injection is safe to use when taken as prescribed by a healthcare professional. However, it may cause some side effects, and you should inform your doctor if you experience any unusual symptoms.